BioArctic AB

BioArctic’s mission is to develop effective treatments for neurodegenerative diseases caused by misfolded proteins. BioArctic’s technology is now applied to other CNS disorders, and novel antibodies are being developed.

 

BioArctic has a propriatery technology by which therapeutic monoclonal antibodies can be developed. These antibodies are highly specific for aggregated/misfolded proteins involved in disorders such as Alzheimer’s and Parkinson’s disease. The antibodies developed by BioArctic have the unique property to reduce toxic aggregated/misfolded proteins in the brain. Reduction of these toxic proteins is believed to be of significant clinical value.

 

Kategorier: Pharma

Gå till BioArctic ABs hemsida